Arie Belldegrun, Director at Allogene Therapeutics, Inc. (ALLO), bought 194,445 shares at $18.00 ($3.5M) on 2018-10-15, disclosed to the SEC on 2019-02-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ALLO | BUY | 2020-06-04 | $6.9M | — | Filing → |
| KITE | SELL | 2017-09-27 | $9.5M | — | Filing → |
| KITE | BUY | 2017-05-09 | $1.2M | — | Filing → |